As of 2026-03-18, the Relative Valuation of XBiotech Inc (XBIT) is (18.60) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.25 USD, the upside of XBiotech Inc based on Relative Valuation is -926.5%.
The range of the Relative Valuation is (16.84) - (21.14) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 21.9x | 19.5x |
| Forward P/E multiples | 16.0x - 21.7x | 18.8x |
| Fair Price | (16.84) - (21.14) | (18.60) |
| Upside | -848.5% - -1039.5% | -926.5% |
| Date | P/E |
| 2026-03-16 | -2.37 |
| 2026-03-13 | -2.38 |
| 2026-03-12 | -2.41 |
| 2026-03-11 | -2.41 |
| 2026-03-10 | -2.40 |
| 2026-03-09 | -2.42 |
| 2026-03-06 | -2.42 |
| 2026-03-05 | -2.38 |
| 2026-03-04 | -2.42 |
| 2026-03-03 | -2.41 |
| 2026-03-02 | -2.39 |
| 2026-02-27 | -2.32 |
| 2026-02-26 | -2.42 |
| 2026-02-25 | -2.43 |
| 2026-02-24 | -2.41 |
| 2026-02-23 | -2.41 |
| 2026-02-20 | -2.38 |
| 2026-02-19 | -2.45 |
| 2026-02-18 | -2.48 |
| 2026-02-17 | -2.41 |
| 2026-02-13 | -2.52 |
| 2026-02-12 | -2.44 |
| 2026-02-11 | -2.44 |
| 2026-02-10 | -2.49 |
| 2026-02-09 | -2.38 |
| 2026-02-06 | -2.44 |
| 2026-02-05 | -2.37 |
| 2026-02-04 | -2.48 |
| 2026-02-03 | -2.47 |
| 2026-02-02 | -2.55 |
| 2026-01-30 | -2.58 |
| 2026-01-29 | -2.61 |
| 2026-01-28 | -2.71 |
| 2026-01-27 | -2.79 |
| 2026-01-26 | -2.77 |
| 2026-01-23 | -2.76 |
| 2026-01-22 | -2.74 |
| 2026-01-21 | -2.62 |
| 2026-01-20 | -2.60 |
| 2026-01-16 | -2.64 |
| 2026-01-15 | -2.60 |
| 2026-01-14 | -2.68 |
| 2026-01-13 | -2.63 |
| 2026-01-12 | -2.60 |
| 2026-01-09 | -2.63 |
| 2026-01-08 | -2.73 |
| 2026-01-07 | -2.58 |
| 2026-01-06 | -2.60 |
| 2026-01-05 | -2.51 |
| 2026-01-02 | -2.45 |